This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Compliance Remove Governance Remove State Policy Related Topics
FDA Health Insurance Public Health Medicaid HIPAA Medicare COVID-19 Hospitals Medicaid Medicare More Related Topics >
article thumbnail

Top Healthcare Policy Developments in 2023; Register for Crowell Health Solutions Webinar

C&M Health Law

DECEMBER 13, 2022

While the EMTALA guidance is currently being challenged in federal court, we expect the Administration to address additional issues related to reproductive health care services, including state policies affecting telehealth and travel restrictions for abortion. Next Steps .

COVID-19 98
COVID-19 Medicare Medicare Hospitals 98
article thumbnail

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

Drug & Device Law

JANUARY 15, 2024

That is significant because, unlike (now) every other state in the country, since 1987 Pennsylvania precedent prohibited defendants from introducing evidence of their compliance with government and/or industry standards (“standards compliance” or “compliance” evidence, for short) in strict liability design defect cases – generally.

Compliance 52
Compliance FDA Governance State Policy 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024